Metagenomi Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.34

+0.08 (+5.93%)

As of Mar 31, 10:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +2,183.6% upside

Low Target $21.05

Average Target $30.60

High Target $40.98

Current Price $1.34

Current
$1.34

Target
$30.60

$21.05 $30.60 avg $40.98

Scenario Analysis

Bear Case

$21.05

1,470.9%

Low target

Base Case

$30.60

+2,183.6%

Avg target

Bull Case

$40.98

+2,958.2%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$3.95

-66.1% from high

52-Week Low

$1.23

+8.9% from low

Target vs 52W High

$30.60

+674.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%